Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric

David C Fajgenbaum1, Ruth-Anne Langan1, Alberto Sada Japp2

  • 1Department of Medicine and.

Insights

Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic illness. Targeting the PI3K/Akt/mTOR pathway with sirolimus shows promise for patients refractory to IL-6 blockade, offering durable remissions.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic disorder characterized by cytokine-induced lymphoproliferation and systemic inflammation.
  • Patients refractory to interleukin-6 (IL-6) blockade lack targeted therapies, necessitating the identification of novel therapeutic targets.
  • The thrombocytopenia, anasarca, fever/elevated C-reactive protein, reticulin myelofibrosis, renal dysfunction, organomegaly (TAFRO) subtype of iMCD presents unique challenges.

Observation:

  • Analysis of IL-6 blockade-refractory iMCD-TAFRO patients revealed increased CD8+ T cell activation.
  • Elevated levels of VEGF-A and heightened activity within the PI3K/Akt/mTOR signaling pathway were observed.
  • Immunohistochemistry confirmed elevated mTOR signaling via phosphorylated S6 in iMCD lymph node tissues.

Findings:

  • Administration of the mTOR inhibitor, sirolimus, significantly reduced CD8+ T cell activation and decreased VEGF-A levels.
  • Sirolimus treatment resulted in durable clinical responses and ongoing remissions in all three treated iMCD-TAFRO patients.
  • The observed responses included remissions lasting 66, 19, and 19 months.

Implications:

  • This study identifies the PI3K/Akt/mTOR signaling pathway as the first pharmacologically targetable mechanism in IL-6 blockade-refractory iMCD.
  • Precision medicine targeting this pathway offers a new therapeutic strategy for iMCD patients with refractory disease.
  • Prospective clinical trials evaluating sirolimus for treatment-refractory iMCD are planned, including NCT03933904.
Abstract

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
4.8K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
129.8K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
67.9K
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
59.5K